ParkinsonFranceV1, PubMed, Curation, bibRecord, 000811

Addictive behaviors and Parkinson's disease.

Identifieur interne : 000811 ( PubMed/Curation ); précédent : 000810; suivant : 000812

Addictive behaviors and Parkinson's disease.

Auteurs : T. Witjas [France] ; A. Eusebio ; F. Fluchère ; J-P Azulay

Source :

Revue neurologique [ 0035-3787 ]

RBID : pubmed:22921247

English descriptors

KwdEn :
- Behavior, Addictive (chemically induced), Behavior, Addictive (epidemiology), Behavior, Addictive (therapy), Brain (drug effects), Brain (physiopathology), Compulsive Behavior (chemically induced), Compulsive Behavior (epidemiology), Compulsive Behavior (therapy), Disruptive, Impulse Control, and Conduct Disorders (chemically induced), Disruptive, Impulse Control, and Conduct Disorders (epidemiology), Disruptive, Impulse Control, and Conduct Disorders (therapy), Dopamine (adverse effects), Dopamine (therapeutic use), Humans, Models, Biological, Parkinson Disease (complications), Parkinson Disease (drug therapy), Parkinson Disease (therapy), Reward.
MESH :
- chemical , adverse effects : Dopamine.
- chemically induced : Behavior, Addictive, Compulsive Behavior, Disruptive, Impulse Control, and Conduct Disorders.
- complications : Parkinson Disease.
- drug effects : Brain.
- drug therapy : Parkinson Disease.
- epidemiology : Behavior, Addictive, Compulsive Behavior, Disruptive, Impulse Control, and Conduct Disorders.
- physiopathology : Brain.
- chemical , therapeutic use : Dopamine.
- therapy : Behavior, Addictive, Compulsive Behavior, Disruptive, Impulse Control, and Conduct Disorders, Parkinson Disease.
- Humans, Models, Biological, Reward.

Abstract

In Parkinson's disease, the degeneration of the dopaminergic system and the longstanding exposure to dopamine replacement therapy (DRT) may cause, in a group of vulnerable patients, dysregulation of the brain reward system.

DOI: 10.1016/j.neurol.2012.06.014
PubMed: 22921247

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000847

Links to Exploration step

pubmed:22921247

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Addictive behaviors and Parkinson's disease.</title>
<author><name sortKey="Witjas, T" sort="Witjas, T" uniqKey="Witjas T" first="T" last="Witjas">T. Witjas</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de neurologie et pathologie du mouvement, hôpital de la Timone, Marseille cedex, France. tatiana.witjas@ap-hm.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de neurologie et pathologie du mouvement, hôpital de la Timone, Marseille cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Eusebio, A" sort="Eusebio, A" uniqKey="Eusebio A" first="A" last="Eusebio">A. Eusebio</name>
</author>
<author><name sortKey="Fluchere, F" sort="Fluchere, F" uniqKey="Fluchere F" first="F" last="Fluchère">F. Fluchère</name>
</author>
<author><name sortKey="Azulay, J P" sort="Azulay, J P" uniqKey="Azulay J" first="J-P" last="Azulay">J-P Azulay</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>2012 Aug-Sep</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:22921247</idno>
<idno type="pmid">22921247</idno>
<idno type="doi">10.1016/j.neurol.2012.06.014</idno>
<idno type="wicri:Area/PubMed/Corpus">000847</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000847</idno>
<idno type="wicri:Area/PubMed/Curation">000811</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000811</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Addictive behaviors and Parkinson's disease.</title>
<author><name sortKey="Witjas, T" sort="Witjas, T" uniqKey="Witjas T" first="T" last="Witjas">T. Witjas</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de neurologie et pathologie du mouvement, hôpital de la Timone, Marseille cedex, France. tatiana.witjas@ap-hm.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Service de neurologie et pathologie du mouvement, hôpital de la Timone, Marseille cedex</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Eusebio, A" sort="Eusebio, A" uniqKey="Eusebio A" first="A" last="Eusebio">A. Eusebio</name>
</author>
<author><name sortKey="Fluchere, F" sort="Fluchere, F" uniqKey="Fluchere F" first="F" last="Fluchère">F. Fluchère</name>
</author>
<author><name sortKey="Azulay, J P" sort="Azulay, J P" uniqKey="Azulay J" first="J-P" last="Azulay">J-P Azulay</name>
</author>
</analytic>
<series><title level="j">Revue neurologique</title>
<idno type="ISSN">0035-3787</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Behavior, Addictive (chemically induced)</term>
<term>Behavior, Addictive (epidemiology)</term>
<term>Behavior, Addictive (therapy)</term>
<term>Brain (drug effects)</term>
<term>Brain (physiopathology)</term>
<term>Compulsive Behavior (chemically induced)</term>
<term>Compulsive Behavior (epidemiology)</term>
<term>Compulsive Behavior (therapy)</term>
<term>Disruptive, Impulse Control, and Conduct Disorders (chemically induced)</term>
<term>Disruptive, Impulse Control, and Conduct Disorders (epidemiology)</term>
<term>Disruptive, Impulse Control, and Conduct Disorders (therapy)</term>
<term>Dopamine (adverse effects)</term>
<term>Dopamine (therapeutic use)</term>
<term>Humans</term>
<term>Models, Biological</term>
<term>Parkinson Disease (complications)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (therapy)</term>
<term>Reward</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Dopamine</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Behavior, Addictive</term>
<term>Compulsive Behavior</term>
<term>Disruptive, Impulse Control, and Conduct Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Behavior, Addictive</term>
<term>Compulsive Behavior</term>
<term>Disruptive, Impulse Control, and Conduct Disorders</term>
</keywords>
<keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Dopamine</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Behavior, Addictive</term>
<term>Compulsive Behavior</term>
<term>Disruptive, Impulse Control, and Conduct Disorders</term>
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
<term>Models, Biological</term>
<term>Reward</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">In Parkinson's disease, the degeneration of the dopaminergic system and the longstanding exposure to dopamine replacement therapy (DRT) may cause, in a group of vulnerable patients, dysregulation of the brain reward system.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">22921247</PMID>
<DateCreated><Year>2012</Year>
<Month>09</Month>
<Day>21</Day>
</DateCreated>
<DateCompleted><Year>2013</Year>
<Month>03</Month>
<Day>04</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>11</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0035-3787</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>168</Volume>
<Issue>8-9</Issue>
<PubDate><MedlineDate>2012 Aug-Sep</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Revue neurologique</Title>
<ISOAbbreviation>Rev. Neurol. (Paris)</ISOAbbreviation>
</Journal>
<ArticleTitle>Addictive behaviors and Parkinson's disease.</ArticleTitle>
<Pagination><MedlinePgn>624-33</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.neurol.2012.06.014</ELocationID>
<ELocationID EIdType="pii" ValidYN="Y">S0035-3787(12)00878-8</ELocationID>
<Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">In Parkinson's disease, the degeneration of the dopaminergic system and the longstanding exposure to dopamine replacement therapy (DRT) may cause, in a group of vulnerable patients, dysregulation of the brain reward system.</AbstractText>
<AbstractText Label="STATE OF THE ARTS" NlmCategory="UNASSIGNED">These patients develop DRT-related compulsions, which include addiction to levodopa or dopamine dysregulation syndrome (DDS), punding, and impulse control disorders (ICDs). ICDs or behavioral addiction reported in Parkinson's disease include pathological gambling, hypersexuality, compulsive buying and binge eating. Although the underlying pathophysiology is still poorly understood, these behaviors are linked by their reward-based and repetitive nature. Such behaviors may result in devastating psychosocial impairment for the patients and are often hidden.</AbstractText>
<AbstractText Label="PERSPECTIVE AND CONCLUSIONS" NlmCategory="UNASSIGNED">The recognition of these behaviors is important and allows a better clinical management. Although the limited data do not permit particular therapeutic strategies, some approaches are worth considering: DRT reduction, trials of non-dopaminergic medications and subthalamic chronic stimulation.</AbstractText>
<CopyrightInformation>Copyright © 2012. Published by Elsevier Masson SAS.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Witjas</LastName>
<ForeName>T</ForeName>
<Initials>T</Initials>
<AffiliationInfo><Affiliation>Service de neurologie et pathologie du mouvement, hôpital de la Timone, Marseille cedex, France. tatiana.witjas@ap-hm.fr</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Eusebio</LastName>
<ForeName>A</ForeName>
<Initials>A</Initials>
</Author>
<Author ValidYN="Y"><LastName>Fluchère</LastName>
<ForeName>F</ForeName>
<Initials>F</Initials>
</Author>
<Author ValidYN="Y"><LastName>Azulay</LastName>
<ForeName>J-P</ForeName>
<Initials>JP</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2012</Year>
<Month>08</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Rev Neurol (Paris)</MedlineTA>
<NlmUniqueID>2984779R</NlmUniqueID>
<ISSNLinking>0035-3787</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>VTD58H1Z2X</RegistryNumber>
<NameOfSubstance UI="D004298">Dopamine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D016739" MajorTopicYN="N">Behavior, Addictive</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
<QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003192" MajorTopicYN="N">Compulsive Behavior</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007174" MajorTopicYN="N">Disruptive, Impulse Control, and Conduct Disorders</DescriptorName>
<QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004298" MajorTopicYN="N">Dopamine</DescriptorName>
<QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008954" MajorTopicYN="N">Models, Biological</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName>
<QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012201" MajorTopicYN="N">Reward</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2012</Year>
<Month>04</Month>
<Day>19</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2012</Year>
<Month>06</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2012</Year>
<Month>06</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2012</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2012</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2013</Year>
<Month>3</Month>
<Day>5</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">22921247</ArticleId>
<ArticleId IdType="pii">S0035-3787(12)00878-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.neurol.2012.06.014</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000811 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000811 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:22921247
   |texte=   Addictive behaviors and Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i   -Sk "pubmed:22921247" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a ParkinsonFranceV1

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Addictive behaviors and Parkinson's disease.

Addictive behaviors and Parkinson's disease.

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki